509 related articles for article (PubMed ID: 12898966)
1. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
[TBL] [Abstract][Full Text] [Related]
2. Increasing level of prostate-specific antigen and prostate cancer risk factors among 193 men examined in screening procedure.
Opalińska E; Michalak A; Stoma F; Latalski M; Goniewicz M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):57-63. PubMed ID: 15323167
[TBL] [Abstract][Full Text] [Related]
3. Screening for prostate cancer in a population of South Poland--studies 2000.
Laskiewicz J; Janik A; Dobrek Ł; Słodowska-Hajduk Z; Matyja A; Thor PJ
Folia Med Cracov; 2003; 44(1-2):159-68. PubMed ID: 15232898
[TBL] [Abstract][Full Text] [Related]
4. [Who works in the prevention and early detection of benign prostatic hyperplasia and prostate cancer in Croatia?].
Kranjcević K; Marković BB
Acta Med Croatica; 2007 Feb; 61(1):45-8. PubMed ID: 17593640
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
6. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia.
Galić J; Simunović D
Coll Antropol; 2008 Dec; 32(4):1195-202. PubMed ID: 19149228
[TBL] [Abstract][Full Text] [Related]
7. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
Madersbacher S
Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
[TBL] [Abstract][Full Text] [Related]
8. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812
[TBL] [Abstract][Full Text] [Related]
9. [A study on the mass screening system for prostatic diseases].
Sakamoto M; Katayama T; Umeda K; Kazama T; Terada T; Fuse H
Hinyokika Kiyo; 1992 Aug; 38(8):907-11. PubMed ID: 1384293
[TBL] [Abstract][Full Text] [Related]
10. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
12. Role of screening in detection of clinically localized prostate cancer.
Galić J; Karner I; Cenan L; Tucak A; Vranjes Z; Bilandzija-Peranović M; Hegedus I
Coll Antropol; 2003; 27 Suppl 1():49-54. PubMed ID: 12955891
[TBL] [Abstract][Full Text] [Related]
13. Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.
Loeb S; Roehl KA; Nadler RB; Yu X; Catalona WJ
J Urol; 2007 Dec; 178(6):2348-52; discussion 2352-3. PubMed ID: 17936844
[TBL] [Abstract][Full Text] [Related]
14. [Prostate tumor and its diagnosis].
Yamanaka H
Rinsho Byori; 2001 Jul; 49(7):633-7. PubMed ID: 11519121
[TBL] [Abstract][Full Text] [Related]
15. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia.
Andriole GL; Roehrborn C; Schulman C; Slawin KM; Somerville M; Rittmaster RS
Urology; 2004 Sep; 64(3):537-41; discussion 542-3. PubMed ID: 15351586
[TBL] [Abstract][Full Text] [Related]
16. Screening for prostate cancer: updated experience from the Tyrol study.
Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
[TBL] [Abstract][Full Text] [Related]
18. Self-reported prostate cancer screening in Austria.
Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G
J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656
[TBL] [Abstract][Full Text] [Related]
19. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men.
Postma R; Schröder FH; van der Kwast TH
Urology; 2005 Apr; 65(4):745-9. PubMed ID: 15833520
[TBL] [Abstract][Full Text] [Related]
20. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
Fawzy A; Fontenot C; Guthrie R; Baudier MM
Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]